Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrase MT20 vs Placebo for Steatorrhea in Cystic Fibrosis
NCT00408317Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2006
- Primary completion
- Apr 2007
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by Forest Laboratories. Started Nov 2006; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00408317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408317.